Suven Pharmaceuticals acquires controlling stake in US-based NJ Bio
Suven Pharmaceuticals Limited has acquired a 56% controlling stake in NJ Bio Inc, a US-based Contract Research and Development Manufacturing Organisation (CRDMO) specialising in antibody-drug conjugates (ADC) and other emerging...